Traditional Chinese medicine versus regular therapy in Henoch-Schönlein purpura nephritis in children: study protocol for a randomized controlled trial
Abstract Background Henoch-Schönlein purpura nephritis (HSPN) is the most common secondary glomerular disease in children. Currently, the treatment for HSPN is always selected based on the Kidney Disease Improving Global Outcomes guidelines; however, this approach may lead to undertreatment, especia...
Main Authors: | Ying Ding, Xia Zhang, Xianqing Ren, Wensheng Zhai, Liyun He, Jianping Liu, Chen Yao, Shanshan Han, Long Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-019-3484-3 |
Similar Items
-
Mycophenolate mofetil for the treatment of Henoch-Schönlein purpura nephritis; current knowledge and new concepts
by: Azar Nickavar, et al.
Published: (2017-07-01) -
Púrpura de Henoch-Schönlein: recorrência e cronicidade Henoch-Schönlein purpura: recurrence and chronicity
by: Camila S. Alfredo, et al.
Published: (2007-04-01) -
Incidence and risk factors of nephritis in childhood Henoch-Schonlein purpura
by: Yaulia Yanrismet, et al.
Published: (2023-08-01) -
Association of Interleukin-2 Gene Polymorphism with Henoch-schönlein Purpura Nephritis
by: Jiajia Cao, et al.
Published: (2023-06-01) -
Significance of glomerular fibrinogen deposition in children with Henoch-Schönlein purpura nephritis
by: Fengying Wang, et al.
Published: (2018-08-01)